Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,262.00
Bid: 1,254.00
Ask: 1,264.00
Change: -76.00 (-5.68%)
Spread: 10.00 (0.797%)
Open: 1,330.00
High: 1,330.00
Low: 1,258.00
Prev. Close: 1,338.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

13 May 2020 10:50

RNS Number : 7802M
Georgia Capital PLC
13 May 2020
 

London, 13 May 2020

 

 

 

Georgia Capital PLC Notice of 1Q20 Trading Update

Georgia Capital PLC ("the Group") will issue a trading update for the first quarter of 2020 on Tuesday, 19 May 2020 at 7:00 London time. The results announcement will be available on the Group's website at www.georgiacapital.ge. An investor/analyst conference call, organised by the Group, will be held on 19 May 2020, at 16:00 UK / 17:00 CET / 11:00 U.S Eastern Time. The duration of the call will be 60 minutes and will consist of a 15-minute update and a 45-minute Q&A session.

 

 

Dial-in numbers:

30-Day replay:

Pass code for replays/Conference ID: 1991857

Pass code for replays / Conference ID: 1991857

International Dial In: +44 (0) 2071 928000

UK Freephone Dial In: 08082380667

UK Freephone Dial In: 08003767922

UK Local Dial In: 08445718951

UK Local Dial In: 08445718892

International Dial In: +44 (0) 3333009785

US: 18669661396

US: 1 (866) 331-1332

 

Name of authorised official of issuer responsible for making notification: Nino Rekhviashvili, Head of Investor Relations

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group seeks to capture growth in the sectors in which it currently operates and drive the development of new high-growth businesses in Georgia, which it intends to add either by acquiring businesses in their early development stage or by establishing greenfield businesses, often consolidating fragmented or underdeveloped markets. The Group currently has nine private businesses: (i) a water utility business (GGU); (ii) a renewable energy business (hydro and wind assets held through GRPC, Hydrolea and Qartli wind farm); (iii) a housing development business (m2, renamed as Georgia Real Estate); (iv) a hospitality and commercial real estate business (m2, renamed as Georgia Real Estate); (v) a property and casualty insurance business (Aldagi); (vi) a beverages business (Georgia Beverages); (vii) an education business (three partners: BGA, Buckswood and Green school); (viii) an auto service business (Greenway and Amboli) and (ix) a digital services business (Redberry). Georgia Capital also has two public company holdings (London Stock Exchange premium-listed Georgian companies): (i) Georgia Healthcare Group PLC ("GHG"), (70.6% equity stake), a UK incorporated holding company of the largest healthcare services provider in Georgia, which is also the largest pharmaceuticals retailer and wholesaler in the country; and (ii) Bank of Georgia Group PLC ("BoG"), (19.9% equity stake), a leading universal bank in Georgia.

 

JSC Georgia Capital has, as of the date hereof, the following credit ratings:

 

 

S&P Global

'B'/FC & 'B'/LC

Moody's

B2/CFR & B2/PDR

 For further information, please visit www.georgiacapital.ge or contact: 

 

Irakli Gilauri

Giorgi Alpaidze

Nino Rekhviashvili

Chairman and Chief Executive

Chief Financial Officer

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+ 995 322 005 045

 

ir@gcap.ge

ir@gcap.ge

 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORGCGDULSBDGGX
Date   Source Headline
26th Apr 20233:44 pmRNSTransaction in Own Shares
25th Apr 20235:32 pmRNSTransaction in Own Shares
24th Apr 20234:21 pmRNSTransaction in Own Shares
24th Apr 20233:34 pmRNSDirector/PDMR Shareholding
20th Apr 20235:34 pmRNSTransaction in Own Shares
19th Apr 20235:33 pmRNSTransaction in Own Shares
18th Apr 20235:49 pmRNSTransaction in Own Shares
14th Apr 20232:56 pmRNSHolding(s) in Company
14th Apr 202311:51 amRNSDirector/PDMR Shareholding
13th Apr 20235:39 pmRNSTransaction in Own Shares
13th Apr 20238:00 amRNSNotice of AGM
13th Apr 20237:00 amRNSTransfer to a Standard Listing on the LSE
12th Apr 20237:00 amRNSLaunch of US$ 10 million share buyback programme
11th Apr 20235:30 pmRNSGeorgia Capital
11th Apr 202311:20 amRNSDirector/PDMR Shareholding
3rd Apr 202312:50 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSUpdate on divestments from subscale businesses
27th Mar 20235:00 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSAnnual Financial Report
20th Mar 20231:16 pmRNSDirector/PDMR Shareholding
14th Mar 202312:36 pmRNSResult of Meeting
10th Mar 20233:23 pmRNSDirector/PDMR Shareholding
6th Mar 20233:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSEducation business continues to expand
28th Feb 20234:32 pmRNSHolding(s) in Company
27th Feb 20233:04 pmRNSDirector/PDMR Shareholding
20th Feb 20233:44 pmRNSDirector/PDMR Shareholding
20th Feb 20237:00 amRNSFinal Results
17th Feb 202310:33 amRNSNotice of GM
14th Feb 202311:00 amRNSNotice of Results
13th Feb 20234:15 pmRNSDirector/PDMR Shareholding
6th Feb 20233:37 pmRNSDirector/PDMR Shareholding
30th Jan 20235:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20235:16 pmRNSDirector/PDMR Shareholding
23rd Jan 20234:59 pmRNSDirector/PDMR Shareholding
20th Jan 20235:33 pmRNSHolding(s) in Company
19th Jan 202311:58 amRNSDirector/PDMR Shareholding
16th Jan 20235:55 pmRNSDirector/PDMR Shareholding
13th Jan 20235:04 pmRNSDirector/PDMR Shareholding
6th Jan 20235:34 pmRNSDirector/PDMR Shareholding
29th Dec 20224:29 pmRNSDirector/PDMR Shareholding
28th Dec 20229:27 amRNSDirector/PDMR Shareholding
20th Dec 202212:57 pmRNSChanges to the Board Committees
19th Dec 20221:01 pmRNSDirector/PDMR Shareholding
19th Dec 202212:58 pmRNSHolding(s) in Company
12th Dec 20221:33 pmRNSDirector/PDMR Shareholding
9th Dec 20224:13 pmRNSHolding(s) in Company
8th Dec 20224:08 pmRNSHolding(s) in Company
8th Dec 20224:05 pmRNSHolding(s) in Company
8th Dec 20224:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.